Trial
NCT04575519
Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Fundació Institut Germans Trias i Pujol
Collaborators
National Center for Tuberculosis and Lung Disease, Tbilisi, Georgia; Perinatal HIV Research Unit of the University of the Witswatersrand
Condition
Tuberculosis, Pulmonary
Intervention
Control group
Why stopped
The impact of the COVID-19 pandemic on TB diagnosis affected greatly the recruitment rate and posed challenges to the trial's timeline, consuming the funding needed to continue the enrolment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-01